Valeant Pharmaceuticals Class Action Lawsuit
Siskinds LLP (“Siskinds”) is co-counsel in proposed securities class actions against Valeant Pharmaceuticals International, Inc. (“Valeant”), certain of its directors and officers, and its auditor PricewaterhouseCoopers LLP (“PwC”). These class actions arise from the circumstances surrounding Valeant’s previously undisclosed relationships with Philidor Rx Services, LLC and other specialty pharmacies in the conduct of its business in the United States.
In October 2015, Siskinds’ Quebec affiliate law firm, Siskinds Desmeules, filed a securities class action against Valeant and certain other defendants. Siskinds Desmeules and its co-counsel have appeared before the Superior Court of Quebec and have set a schedule to advance the action expeditiously.
Siskinds is also co-counsel in a parallel Ontario action currently pending before the Ontario Superior Court of Justice.
The class actions have been brought on behalf of a class of investors who purchased Valeant’s common shares and notes. If you purchased Valeant’s common shares or notes, please click the ‘Receive updates on this case’ button below and complete the form. Your information will be held in strict confidence. By completing the form, you are not retaining Siskinds, nor do you incur any obligations in connection with this lawsuit.